Inventor · disambiguated record
David Meloni
Also filed as: MELONI DAVID · MELONI DAVID J · MELONI DAVID JOHN
25 granted patents·8 pending applications·424 citations·filing 1998–2025
96Inventor score
Files withINCYTE CORP20INCYTE HOLDINGS CORP3ZHOU JIACHENG3BRISTOL MYERS SQUIBB PHARMA CO2XUE CHU-BIAO2
Top patents by PatentIndex Score
33 records- 0198US11753406B2Salts of a PD-1/PD-L1 inhibitorINCYTE CORP·Filed 2020·Granted Sep 12, 2023·9 cites·23 claims
- 0298US9290506B2Processes for preparing JAK inhibitors and related intermediate compoundsINCYTE CORP·Filed 2015·Granted Mar 22, 2016·60 cites·1 claims
- 0398US9000161B2Processes for preparing JAK inhibitors and related intermediate compoundsZHOU JIACHENG·Filed 2013·Granted Apr 7, 2015·67 cites·25 claims
- 0498US8993582B2Processes for preparing JAK inhibitors and related intermediate compoundsZHOU JIACHENG·Filed 2013·Granted Mar 31, 2015·60 cites·1 claims
- 0598US8410265B2Processes for preparing JAK inhibitors and related intermediate compoundsZHOU JIACHENG·Filed 2010·Granted Apr 2, 2013·136 cites·4 claims
- 0696US11905292B2Process and intermediates for preparing a JAK inhibitorINCYTE CORP·Filed 2021·Granted Feb 20, 2024·4 cites·69 claims
- 0795US9908888B2Processes for preparing pyrazolyl-substituted pyrrolo[2,3-d]pyrimidinesINCYTE HOLDINGS CORP·Filed 2016·Granted Mar 6, 2018·6 cites·8 claims
- 0894US12071439B2Process and intermediates for preparing a JAK inhibitorINCYTE CORP·Filed 2022·Granted Aug 27, 2024·2 cites·31 claims
- 0994US11897889B2Process and intermediates for preparing a JAK1 inhibitorINCYTE CORP·Filed 2021·Granted Feb 13, 2024·2 cites·69 claims
- 1094US11084822B2Salts and processes of preparing a PI3K inhibitorINCYTE CORP·Filed 2019·Granted Aug 10, 2021·7 cites·37 claims
- 1194US10336759B2Salts and processes of preparing a PI3K inhibitorINCYTE CORP·Filed 2016·Granted Jul 2, 2019·18 cites·8 claims
- 1292US9321755B2Process for the synthesis of an indoleamine 2,3-dioxygenase inhibitorINCYTE CORP·Filed 2014·Granted Apr 26, 2016·15 cites·66 claims
- 1389US12024522B2Salts and processes of preparing a PI3K inhibitorINCYTE CORP·Filed 2021·Granted Jul 2, 2024·1 cites·48 claims
- 1485US10280157B2Process for the synthesis of an indoleamine 2,3-dioxygenase inhibitorINCYTE CORP·Filed 2017·Granted May 7, 2019·3 cites·12 claims
- 1584US7678798B2Piperazinylpiperidine derivatives as chemokine receptor antagonistsINCYTE CORP·Filed 2005·Granted Mar 16, 2010·5 cites·35 claims
- 1681US12428426B2Process and intermediates for preparing a JAK1 inhibitorINCYTE CORP·Filed 2023·Granted Sep 30, 2025·0 cites·73 claims
- 1781US9873688B2Process for the synthesis of an indoleamine 2,3-dioxygenase inhibitorINCYTE CORP·Filed 2016·Granted Jan 23, 2018·2 cites·6 claims
- 1881US2025270221A1Solid forms of jak inhibitor and process of preparing the sameINCYTE CORP·Filed 2025·Application pending·0 cites
- 1980US6667332B2Efficient process for the preparation of a factor Xa inhibitorBRISTOL MYERS SQUIBB PHARMA CO·Filed 2001·Granted Dec 23, 2003·11 cites·35 claims
- 2080US2025129079A1Salts and processes of preparing a pi3k inhibitorINCYTE CORP·Filed 2024·Application pending·0 cites
- 2179US8268826B2Piperazinylpiperidine derivatives as chemokine receptor antagonistsXUE CHU-BIAO·Filed 2009·Granted Sep 18, 2012·3 cites·17 claims
- 2278US12247030B2Process for preparing compositions comprising an enantiomeric excess of a substituted pyrrolo[2,3-d]pyrimidineINCYTE HOLDINGS CORP·Filed 2021·Granted Mar 11, 2025·0 cites·10 claims
- 2378US2025026760A1Solid forms of jak inhibitor and process of preparing the sameINCYTE CORP·Filed 2024·Application pending·0 cites
- 2478US2025340559A1Processes for preparing jak inhibitors and related intermediate compoundsINCYTE HOLDINGS CORP·Filed 2025·Application pending·0 cites
- 2577US2024368171A1Process and intermediates for preparing a jak inhibitorINCYTE CORP·Filed 2024·Application pending·0 cites
- 2673US2023399331A1Solid forms of jak inhibitor and process of preparing the sameINCYTE CORP·Filed 2023·Application pending·0 cites
- 2771US6747158B2Efficient process for the preparation of a factor Xa inhibitorBRISTOL MYERS SQUIBB PHARMA CO·Filed 2003·Granted Jun 8, 2004·4 cites·25 claims
- 2866US6770763B2Asymmetric synthesis of amino-pyrrolidinonesBRISTOL MYERS SQUIBB CO·Filed 2003·Granted Aug 3, 2004·4 cites·12 claims
- 2961US9067921B2Piperazinylpiperidine derivatives as chemokine receptor antagonistsINCYTE CORP·Filed 2014·Granted Jun 30, 2015·0 cites·7 claims
- 3057US8680104B2Piperazinylpiperidine derivatives as chemokine receptor antagonistsXUE CHU-BIAO·Filed 2012·Granted Mar 25, 2014·0 cites·9 claims
- 3156US2013225556A1Azetidine and cyclobutane derivatives as jak inhibitorsINCYTE CORP·Filed 2013·Application pending·0 cites
- 3254US2004198787A1Efficient process for the preparation of a factor Xa inhibitorFiled 2004·Application pending·0 cites
- 3342US6306886B1Crystalline roxifibanDU PONT PHARM CO·Filed 1998·Granted Oct 23, 2001·5 cites·30 claims
Join the waitlist — get patent alerts
Get an alert when David Meloni files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →